181 related articles for article (PubMed ID: 37435919)
21. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
22. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
Ozkan E; Soydal C; Araz M; Aras G; Ibis E
Clin Nucl Med; 2012 Aug; 37(8):755-8. PubMed ID: 22785502
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.
Neshandar Asli I; Siahkali AS; Shafie B; Javadi H; Assadi M
Mol Imaging Radionucl Ther; 2014 Jun; 23(2):54-9. PubMed ID: 24963446
[TBL] [Abstract][Full Text] [Related]
25. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
26. Thyroglobulin is a poor predictor of differentiated thyroid cancer in patients who undergo surgery for thyroid nodular diseases.
Rigbi S; Joshua BZ; Baraf L; Yoel U; Fraenkel M
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1311-1319. PubMed ID: 36205785
[TBL] [Abstract][Full Text] [Related]
27. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
28. Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor® Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma.
Giovanella L; Verburg FA; Trimboli P; Imperiali M; Keller F; Ceriani L
Clin Chem Lab Med; 2019 Jul; 57(8):1185-1191. PubMed ID: 30835250
[TBL] [Abstract][Full Text] [Related]
29. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.
Qin J; Yu Z; Guan H; Shi L; Liu Y; Zhao N; Shan Z; Han C; Li Y; Teng W
Dis Markers; 2015; 2015():648670. PubMed ID: 26600670
[TBL] [Abstract][Full Text] [Related]
30. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [
Albano D; Tulchinsky M; Dondi F; Mazzoletti A; Lombardi D; Bertagna F; Giubbini R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):461-468. PubMed ID: 32794104
[TBL] [Abstract][Full Text] [Related]
32. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
33. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
Küçük ON; Gültekin SS; Aras G; Ibiş E
Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of Tg and TgAb for metastasis following ablation in patients with differentiated thyroid carcinoma coexistent with Hashimoto thyroiditis.
Chai H; Zhu ZJ; Chen ZQ; Yu YL
Endocr Res; 2016 Aug; 41(3):218-22. PubMed ID: 27158852
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the value of first thyroglobulin determination in the diagnostics of metastases immediately following differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Rutkowski A; Mikosiński S; Knapska-Kucharska M; Gonerska-Szadkowska A; Oszukowska L; Karwowska A; Lewiński A
Endokrynol Pol; 2006; 57(4):370-3. PubMed ID: 17006838
[TBL] [Abstract][Full Text] [Related]
37. Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.
Aydin F; Sipahi M; Budak ES; Oner AO; Demirelli S; Erkilic M; Gungor F
Ann Nucl Med; 2016 Jan; 30(1):60-7. PubMed ID: 26462671
[TBL] [Abstract][Full Text] [Related]
38. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
39. The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
Liu Y
Nucl Med Commun; 2016 Jun; 37(6):577-82. PubMed ID: 26813991
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]